Bone development in female rats maintained with soy-free or soy-containing food as determined by computer-assisted tomography and serum bone markers
- 4 July 2008
- journal article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 26 (4) , 321-327
Abstract
The development of bone in immature rats and in aged rats has not been thoroughly studied. Therefore, we investigated the development of bones in young, middleaged, and aged female rats. Because most rat chows contain soy proteins, including estrogenic isoflavones, as a source of protein, comparison of effects on mineral density and on areas of the cancellous and cortical parts of the metaphysis of the tibia as measured by quantitative computer tomography in animals fed with soy-free and soy-containing food was made. As surrogate parameters of bone metabolism serum, osteocalcin (OC) and the breakdown products of bone collagen—the Crosslaps—were also determined. The cancellous density increased between day 25 after birth to reach peak bone mass at 90 days of age; in 18-and 20-month-old animals, significant reduction was observed that was more profound in the animals fed with soy-free food. Serum OC and the Crosslaps were highest in 15-day-old and lowest in 9-, 18-, and 20-month-old animals. Animals fed with soy-containing food had significantly higher osteocalcin levels at day 15 and at 9 and 18 months of age. In the aged animals, intake of soy isoflavones that have an estrogenic effect appears to exert beneficial effects as these aged animals lost less cancellous bone, as indicated by their surrogate parameters of metabolism in the serum. It is concluded that exorbitantly high bone turnover is present in immature and peripubertal rats. Raising and keeping female rats under soy-free or soy-containing conditions has marked effects on several bone parameters that are of particular relevance in aged animals.Keywords
This publication has 29 references indexed in Scilit:
- Isoflavone metabolites and their in vitro dual functions: They can act as an estrogenic agonist or antagonist depending on the estrogen concentrationThe Journal of Steroid Biochemistry and Molecular Biology, 2006
- Combined Effects of Physical Activity, Dietary Isoflavones and 17β-Estradiol on Movement Drive, Body Weight and Bone Mineral Density in Ovariectomized Female RatsPlanta Medica, 2006
- Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatmentJournal of Endocrinology, 2006
- Comparison of effects of estradiol (E2) with those of octylmethoxycinnamate (OMC) and 4-methylbenzylidene camphor (4MBC) — 2 filters of UV light – on several uterine, vaginal and bone parametersToxicology and Applied Pharmacology, 2006
- Skeletal Consequences of Hormone Therapy Discontinuance: A Systematic ReviewObstetrical & Gynecological Survey, 2006
- Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in miceAPMIS, 2005
- Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite of extensive proliferationBiochemical and Biophysical Research Communications, 2005
- Effects of age, reproductive status and ambient temperature on skin temperature regulation in the female ratMaturitas, 1995
- Histologic evidence for osteopenia and increased bone turnover in ovariectomized ratsBone, 1986
- Dopaminergic neuronal function, anterior pituitary dopamine content, and serum concentrations of prolactin, luteinizing hormone and progesterone in the aged female ratBrain Research, 1982